Skip to main content
Premium Trial:

Request an Annual Quote

Trovagene Eyes $6.1M in Public Offering

NEW YORK (GenomeWeb News) – Trovagene said in a regulatory filing on Wednesday that it is publicly offering $6.1 million of its common stock.

In total, the company plans on offering more than 1.2 million shares, which will be issued upon the exercise of outstanding warrants that Trovagene issued in mid-2012 as part of a public offering when the company moved to the Nasdaq.

The common stock offering is part of a $150 million shelf registration that the company filed with SEC earlier this week.

The San Diego-based molecular diagnostics firm will offer up to 1.15 million shares of its stock at $5.32 per share from time to time upon the exercise of the currently outstanding warrants, it said in a document filed with the US Securities and Exchange Commission. It also will issue up to 92,000 shares at $7 per share from time to time upon exercise of the outstanding warrants issued to the underwriter and its designees.

The $6.1 million in net proceeds expected from the offering will go toward R&D, working capital, and general corporate purposes. Trovagene said it expects to have about 16.8 million shares of its common stock outstanding if all the warrants in the offering are exercised.

Shares of Trovagene were down 6 percent at $6.46 in afternoon trading.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.